MedAdvisor Limited (ASX:MDR) Implements Trading Halt Pending Acquisition Proposal
Trading Halt Request
MedAdvisor Limited (ASX:MDR) has requested a trading halt for its securities, effective immediately, pending the release of an announcement regarding a strategic acquisition proposal for its ANZ business division. The halt will remain in place until the announcement is made or normal trading resumes on Friday, 9 May 2025.
Acquisition Proposal
The trading halt follows a non-binding proposal to acquire MedAdvisor’s ANZ business division, lodged earlier this morning on the ASX Market Announcements Platform.
Motley Fool contributor Abbie Stokes has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended MedAdvisor. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
